ARBUTUS BIOPHARMA CORPORATION — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-28.2% -$37M
$95M
Current Assets↓-25.8% -$33M
$94M
Cash & Equivalents↓-50.4% -$18M
$18M
ST Investments↓-14.9% -$13M
$73M
Receivables↓-39.9% -$962K
$1M
Net PPE↓-99.0% -$3M
$32K
Goodwill
—
Intangibles
—
Total Liabilities↓-47.5% -$16M
$18M
Current Liabilities↓-61.5% -$10M
$6M
Long-Term Debt
$0
Stockholders Equity↓-21.4% -$21M
$77M
Retained Earnings↓-2.5% -$34M
$-1.38B
Operating Lease ROU Asset↓-100.0% -$1M
$0
Operating Lease Liability↓-7.4% -$60K
$746K
Gross PP&E↓-98.5% -$16M
$245K
Accumulated Depreciation↓-98.4% -$13M
$213K
Total Debt Carrying Amount
$0
Contract Liability↓-100.0% -$11M
$0
Contract Liability (Current)
—